Life Sciences Technology Leaders Continue to Join Zinc Ahead
News Jun 21, 2014
Zinc Ahead has announced the appointment of Michael Naimoli as Vice President of US Operations.
Michael brings a wide range of experience to Zinc having worked in senior level positions for both pharmaceutical companies as well as industry leading software providers.
Most recently, Michael served as Global Vice President, Life Sciences Industry Business Unit, for SAP where he was responsible for the direction and management of new offerings for the life sciences industry.
Prior to that, Michael served as Managing Director, Life Sciences, for Microsoft, and started his career in the life sciences industry where he served at Merck, GSK and Charles River Laboratories.
Based in Princeton, New Jersey, Michael will have senior oversight of US operations and client management. Michael and his team will ensure that Zinc’s US operations continue to excel in customer satisfaction and deliver on Zinc Ahead’s rapid growth. The team will also focus on providing valuable insights and actionable intelligence to Zinc’s burgeoning life sciences community.
“Mike’s appointment is part of our ongoing strategy to deepen our investment in the US and support our accelerated growth in the Americas.” said James Brown, Zinc CEO. “The continued addition of industry heavyweights to the executive team at Zinc further underscores Zinc’s commitment to experienced leadership and vision for the management of rich digital media in the life sciences marketplace.”
David Bennett, President Sales and Marketing added, “As Zinc Ahead continues to experience significant growth in the US and around the world, Zinc maintains its marketplace differentiation through its depth and breadth of life sciences experience. We understand that customers want more from us than best-of-breed technology and we are delighted to welcome Mike to the team. His expertise will continue to raise the bar for Zinc’s best in class rich digital media solutions.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE